Correlation Between ATT and BridgeBio Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATT and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and BridgeBio Pharma, you can compare the effects of market volatilities on ATT and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and BridgeBio Pharma.

Diversification Opportunities for ATT and BridgeBio Pharma

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between ATT and BridgeBio is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of ATT i.e., ATT and BridgeBio Pharma go up and down completely randomly.

Pair Corralation between ATT and BridgeBio Pharma

Taking into account the 90-day investment horizon ATT is expected to generate 2.81 times less return on investment than BridgeBio Pharma. But when comparing it to its historical volatility, ATT Inc is 4.44 times less risky than BridgeBio Pharma. It trades about 0.21 of its potential returns per unit of risk. BridgeBio Pharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2,450  in BridgeBio Pharma on August 30, 2024 and sell it today you would earn a total of  299.00  from holding BridgeBio Pharma or generate 12.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ATT Inc  vs.  BridgeBio Pharma

 Performance 
       Timeline  
ATT Inc 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in ATT Inc are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, ATT unveiled solid returns over the last few months and may actually be approaching a breakup point.
BridgeBio Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days BridgeBio Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, BridgeBio Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

ATT and BridgeBio Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATT and BridgeBio Pharma

The main advantage of trading using opposite ATT and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.
The idea behind ATT Inc and BridgeBio Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules